It contains two mechanistically distinct synthetic peptides: BPC-157 Body Protection Compound 157, a 15-amino-acid synthetic gastric pentadecapeptide (CAS 137525-51-0, MW 1,419.5 g/mol) TB-500 a 17-amino-acid synthetic fragment of Thymosin Beta-4 (CAS 885340-08-9, MW ~4,963 g/mol), specifically the LKKTET-containing active domain At Arma Peptides , the blend is supplied at 20mg total 10mg BPC-157 and 10mg TB-500 in a 1:1 ratio, lyophilised as a white powder, verified at 99% purity by HPLC and mass spectrometry
It may occur through mechanisms including hypoglycaemia (especially when combined with insulin or sulphonylureas), dehydration from gastrointestinal side effects, orthostatic hypotension, or reduced caloric intake
16 : 973975 Lassmann H, Fischer P, Jellinger K
No human clinical trials have been published to date
This can lead to the onset of different health problems including, a weak immune system, increased cellular damage, unhealthy liver, etc
11 Given warnings of benign and malignant neoplasms in patients treated with mecasermin, do the benefits of treatment outweigh the potential harms
